A randomized controlled trial reported that chronic supplementation of a TRPV1 agonist (capsaicin) in aged patients with oropharyngeal dysphagia increased the salivary substance P levels as well as improving swallowing function [113]. Here, TRPV1 is linked to Oral-pharyngeal dysphagia.